GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (OTCPK:FSPKF) » Definitions » PS Ratio

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) PS Ratio : 9.06 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Fisher & Paykel Healthcare PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Fisher & Paykel Healthcare's share price is $16.14. Fisher & Paykel Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.78. Hence, Fisher & Paykel Healthcare's PS Ratio for today is 9.06.

Warning Sign:

Fisher & Paykel Healthcare Corp Ltd stock PS Ratio (=10.38) is close to 3-year high of 10.59

The historical rank and industry rank for Fisher & Paykel Healthcare's PS Ratio or its related term are showing as below:

FSPKF' s PS Ratio Range Over the Past 10 Years
Min: 3.44   Med: 8.06   Max: 17.14
Current: 9.66

During the past 13 years, Fisher & Paykel Healthcare's highest PS Ratio was 17.14. The lowest was 3.44. And the median was 8.06.

FSPKF's PS Ratio is ranked worse than
82.2% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 3.28 vs FSPKF: 9.66

Fisher & Paykel Healthcare's Revenue per Sharefor the six months ended in Sep. 2023 was $0.83. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.78.

Good Sign:

Fisher & Paykel Healthcare Corp Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Fisher & Paykel Healthcare was 16.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 13.50% per year.

During the past 13 years, Fisher & Paykel Healthcare's highest 3-Year average Revenue per Share Growth Rate was 26.20% per year. The lowest was -2.60% per year. And the median was 10.75% per year.

Back to Basics: PS Ratio


Fisher & Paykel Healthcare PS Ratio Historical Data

The historical data trend for Fisher & Paykel Healthcare's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare PS Ratio Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.46 13.81 9.55 8.60 9.77

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8.60 - 9.77 -

Competitive Comparison of Fisher & Paykel Healthcare's PS Ratio

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's PS Ratio distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's PS Ratio falls into.



Fisher & Paykel Healthcare PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Fisher & Paykel Healthcare's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=16.14/1.782
=9.06

Fisher & Paykel Healthcare's Share Price of today is $16.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.78.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Fisher & Paykel Healthcare  (OTCPK:FSPKF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Fisher & Paykel Healthcare PS Ratio Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Headlines

From GuruFocus

Fisher & Paykel Healthcare Corp Ltd's Dividend Analysis

By GuruFocus Research 12-04-2023